Hariharan Easwaran

7.0k citations

48 papers · 3.9k indexed · 1 hit paper · h-index 27

Cancer Research top 2%
- Cancer Genomics and Diagnostics 6
Molecular Biology top 2%
- Epigenetics and DNA Methylation 39
- Cancer-related gene regulation 13
- RNA modifications and cancer 12
- Genomics and Chromatin Dynamics 10
- Histone Deacetylase Inhibitors Research 7
- DNA Repair Mechanisms 4
Oncology top 5%
Immunology top 10%
Genetics top 5%
- Genetics and Neurodevelopmental Disorders 4

Co-authors: Stephen B. Baylin Hsing-Chen Tsai M. Cristina Cardoso Heinrich Leonhardt Leander Van Neste Yi Cai Nita Ahuja Heather M. O’Hagan
Cited by: Cancer Research Molecular Biology Oncology
Partner nations: United States Germany Belgium

In The Last Decade

Hariharan Easwaran

48 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2014 Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance

Peers

Countries citing papers authored by Hariharan Easwaran

Since Specialization

Citations

This map shows the geographic impact of Hariharan Easwaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hariharan Easwaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hariharan Easwaran more than expected).

Fields of papers citing papers by Hariharan Easwaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hariharan Easwaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hariharan Easwaran. The network helps show where Hariharan Easwaran may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hariharan Easwaran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hariharan Easwaran Line = papers co-authored together Hariharan Easwaran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Unravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer Hariharan Easwaran,Ashani T. Weeraratna	2025	1
2	DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentation Michaël Noë,Dimitrios Mathios,Akshaya V. Annapragada,Shashikant Koul,Zacharia H. Foda,Jamie E. Medina,Stephen Cristiano,Christopher Cherry,Daniel C. Bruhm,Noushin Niknafs,Vilmos Adleff,Leonardo Ferreira,Hariharan Easwaran,Stephen B. Baylin,Jillian Phallen,Robert B. Scharpf,Victor E. Velculescu	2024	10
3	Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element Loci Tomas Kanholm,Uzma Rentia,Melissa Hadley,Jennifer A. Karlow,Olivia L. Cox,Noor Diab,Matthew L. Bendall,Tyson Dawson,James I. McDonald,Wenbing Xie,Keith A. Crandall,Kathleen H. Burns,Stephen B. Baylin,Hariharan Easwaran,Katherine B. Chiappinelli	2023	13
4	Matrix factorization and transfer learning uncover regulatory biology across multiple single-cell ATAC-seq data sets Rossin Erbe,Michael D. Kessler,Alexander V. Favorov,Hariharan Easwaran,Daria A. Gaykalova,Elana J. Fertig	2020	5
5	Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties Xiangqian Kong,Jie Chen,Wenbing Xie,Stephen M. Brown,Yi Cai,Kaichun Wu,Daiming Fan,Yongzhan Nie,Srinivasan Yegnasubramanian,Rochelle L. Tiedemann,Yong Tao,Ray-Whay Chiu Yen,Michael J. Topper,Cynthia A. Zahnow,Hariharan Easwaran,Scott B. Rothbart,Limin Xia,Stephen B. Baylin	2019	101
6	Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines Eniko Papp,Dorothy Hallberg,Gottfried E. Konecny,Daniel C. Bruhm,Vilmos Adleff,Michaël Noë,Ioannis Kagiampakis,Doreen N. Palsgrove,Dylan Conklin,Yasuto Kinose,James R. White,Michael F. Press,Ronny Drapkin,Hariharan Easwaran,Stephen B. Baylin,Dennis J. Slamon,Victor E. Velculescu,Robert B. Scharpf	2018	78
7	A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine Benjamin R. Leadem,Ioannis Kagiampakis,Catherine Wilson,Tommy K. Cheung,David Arnott,Patrick Trojer,Marie Classon,Hariharan Easwaran,Stephen B. Baylin	2017	37
8	Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations Michelle Vaz,Stephen Y. Hwang,Ioannis Kagiampakis,Jillian Phallen,Ashwini Patil,Heather M. O’Hagan,Lauren Murphy,Cynthia A. Zahnow,Edward Gabrielson,Victor E. Velculescu,Hariharan Easwaran,Stephen B. Baylin	2017	141
9	Genome-wide positioning of bivalent mononucleosomes Subhojit Sen,Kirsten F. Block,Alice Pasini,Stephen B. Baylin,Hariharan Easwaran	2016	21
10	Functional Identification of Cancer-Specific Methylation of CDO1 , HOXA9 , and TAC1 for the Diagnosis of Lung Cancer John Wrangle,Emi Ota Machida,Ludmila Danilova,Alicia Hulbert,Noreli Franco,Wei Zhang,Sabine C. Glöckner,Mathewos Tessema,Leander Van Neste,Hariharan Easwaran,Kornel E. Schuebel,Julien Licchesi,Craig M. Hooker,Nita Ahuja,Jun Amano,Steven A. Belinsky,Stephen B. Baylin,James G. Herman,Malcolm V. Brock	2014	65
11	Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis Yen‐Yi Juo,Fabian M. Johnston,Dongyu Zhang,Hsin-Hsuan Juo,Haopeng Wang,Emmanouil P. Pappou,Tosol Yu,Hariharan Easwaran,Stephen B. Baylin,Manon van Engeland,Nita Ahuja	2014	131
12	Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer Frank P. Vendetti,Michael J. Topper,Peng Huang,Irina Dobromilskaya,Hariharan Easwaran,John Wrangle,Stephen B. Baylin,John T. Poirier,Charles M. Rudin	2014	24
13	Oxidative Damage Targets Complexes Containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG Islands Heather M. O’Hagan,Wei Wang,Subhojit Sen,Christina E. DeStefano Shields,Stella S. Lee,Yang W. Zhang,Eriko G. Clements,Yi Cai,Leander Van Neste,Hariharan Easwaran,Robert A. Casero,Cynthia L. Sears,Stephen B. Baylin	2011	439
14	Aberrant Silencing of Cancer-Related Genes by CpG Hypermethylation Occurs Independently of Their Spatial Organization in the Nucleus Hariharan Easwaran,Leander Van Neste,Leslie Cope,Subhojit Sen,Helai P. Mohammad,Gayle J. Pageau,Jeanne B. Lawrence,James G. Herman,Kornel E. Schuebel,Stephen B. Baylin	2010	23
15	Role of Nuclear Architecture in Epigenetic Alterations in Cancer Hariharan Easwaran,Stephen B. Baylin	2010	10
16	Polycomb CBX7 Promotes Initiation of Heritable Repression of Genes Frequently Silenced with Cancer-Specific DNA Hypermethylation Helai P. Mohammad,Yi Cai,Kelly M. McGarvey,Hariharan Easwaran,Leander Van Neste,Joyce E. Ohm,Heather M. O’Hagan,Stephen B. Baylin	2009	61
17	MS-qFRET: A quantum dot-based method for analysis of DNA methylation Vasudev J. Bailey,Hariharan Easwaran,Yi Zhang,Elizabeth A. Griffiths,Steven A. Belinsky,James G. Herman,Stephen B. Baylin,Hetty E. Carraway,Tza‐Huei Wang	2009	97
18	Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors Joo Mi Yi,Hsing-Chen Tsai,Sabine C. Glöckner,Steven H. Lin,Joyce E. Ohm,Hariharan Easwaran,C. David James,J Costello,Gregory J. Riggins,Charles G. Eberhart,John Laterra,Angelo L. Vescovi,Nita Ahuja,James G. Herman,Kornel E. Schuebel,Stephen B. Baylin	2008	115
19	Distribution of DNA replication proteins in Drosophila cells Hariharan Easwaran,Heinrich Leonhardt,M. Cristina Cardoso	2007	8
20	Replication‐independent chromatin loading of Dnmt1 during G2 and M phases Hariharan Easwaran,Lothar Schermelleh,Heinrich Leonhardt,M. Cristina Cardoso	2004	130

About Hariharan Easwaran

Hariharan Easwaran is a scholar working on Molecular Biology, Cancer Research and Transplantation, having authored 48 papers that have together received 3.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (39 papers), Cancer-related gene regulation (13 papers), RNA modifications and cancer (12 papers), Genomics and Chromatin Dynamics (10 papers), Histone Deacetylase Inhibitors Research (7 papers), Cancer Genomics and Diagnostics (6 papers), DNA Repair Mechanisms (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). The work is most often cited by research in Cancer Research (844 citations), Molecular Biology (3.1k citations) and Oncology (833 citations). Hariharan Easwaran has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Stephen B. Baylin, Hsing-Chen Tsai, Stephen B. Baylin, M. Cristina Cardoso, Heinrich Leonhardt, Leander Van Neste, Yi Cai, Nita Ahuja, Heather M. O’Hagan and Nita Ahuja.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact